ROIV
Roivant Sciences·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ROIV fundamentals
Roivant Sciences (ROIV) released its earnings on Nov 10, 2025: revenue was 1.57M (YoY -64.96%), missed estimates; EPS was -0.17 (YoY +32.00%), beat estimates.
Revenue / YoY
1.57M
-64.96%
EPS / YoY
-0.17
+32.00%
Report date
Nov 10, 2025
ROIV Earnings Call Summary for Q2,2026
- Breakthrough DM Data: Brepocitinib Phase III success sets up 2026 launch, targeting $1B+ peak sales in DM.
- Graves' Dominance: Batoclimab 80% remission rate vs. ATDs; 75% on low/no therapy at 6 months.
- Pipeline Powerhouse: 11 registrational trials across 1402, with $4.4B cash to fuel growth.
- Litigation Risk Management: 1498 defense limits Moderna damages exposure; international trials could accelerate resolution.
EPS
Revenue
Revenue & Expenses
ROIV has released its 2026 Q2 earnings report, with revenue of 1.57M, reflecting a YoY change of -64.89%, and net profit of -166.04M, showing a YoY change of 40.68%. The Sankey diagram below clearly presents ROIV's revenue sources and cost distribution.
Key Indicators
Roivant Sciences (ROIV) key financial stats and ratios, covering profitability, financial health, and leverage.
Roivant Sciences (ROIV)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Roivant Sciences (ROIV)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Roivant Sciences (ROIV)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Roivant Sciences (ROIV) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Roivant Sciences (ROIV) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Roivant Sciences's management provide for the next earnings period?Did Roivant Sciences beat or miss consensus estimates last quarter?What were the key takeaways from Roivant Sciences's earnings call?What does Roivant Sciences do and what are its main business segments?What is Roivant Sciences's latest dividend and current dividend yield?What were the key takeaways from Roivant Sciences’s earnings call?What is the market's earnings forecast for Roivant Sciences next quarter?What is Roivant Sciences's gross profit margin?
